Learn more

UNIV HONG KONG BAPTIST

Overview
  • Total Patents
    106
  • GoodIP Patent Rank
    33,418
About

UNIV HONG KONG BAPTIST has a total of 106 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, computer technology and organic fine chemistry are SBI PHARMACEUTICALS CO LTD, CEVA SANTE ANIMALE SA and ANJI PHARMA US LLC.

Patent filings per year

Chart showing UNIV HONG KONG BAPTISTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bian Zhaoxiang 22
#2 Lu Aiping 19
#3 Xu Hongxi 16
#4 Yang Dajian 16
#5 Chen Shilin 16
#6 Chan Albert Sun Chi 11
#7 Chen Kaixian 11
#8 Chan Albert Sun-Chi 9
#9 Li Min 9
#10 Liu Jiming 8

Latest patents

Publication Filing date Title
US2015231090A1 Usage of guttiferone k for treating high metastatic cancer
US2015196611A1 Pharmaceutical composition and methods for modulating immune system, preventing, pretreating and/or treating cancers
US2015250741A1 MTOR-independent activator of TFEB for autophagy enhancement and uses thereof
US2015038569A1 Anti-cervical cancer compound and method of use thereof
US2014370134A1 Composition comprising Rhizoma coptidis, Cortex phellodendri and Fructus gardeniae and for treating neurodegenerative diseases
US2015126463A1 Use of herbal saponins to regulate gut microflora
US2014353522A1 Apparatus and methodology for flow fluorescence microscopic imaging
US2014212360A1 Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation
US2015261936A1 Method for Separating and Analyzing Overlapping Data Components with Variable Delays in Single Trials
US2015239763A1 Biogenic flocculant composition to enhance flocculation and dewaterability of chemically enhanced primary treatment sludge
CN104840415A Long-acting controlled release liposome gel combination containing blood sugar reducing active component, and preparation method thereof
US2014194499A1 Polyprenylated Benzoylphloroglucinols With Anticancer Activity
US2014194528A1 Usage of sodium houttuyfonate on inhibiting idiopathic pulmonary fibrosis and bleomycin induced pulmonary fibrosis
US2014194529A1 Usage of natural compound for treating inflammation and cancer
US2014194498A1 Polyisoprenylated tetracyclic xanthone with anticancer activity
US2015011646A1 Usage of guttiferone k, a natural compound from garcinia yunnanensis hu on treating high metastatic esophageal cancer
US2014200265A1 Usage of 1,3,5,7-tetrahydroxy-8-isoprenylxanthone for treating inflammation
US2014187626A1 Oxanorbornadiene derivatives and their anticancer activities
WO2015085447A1 New triptolide derivatives and preparation method and use thereof
US2015085817A1 Method for achieving rendezvous for cognitive radio networks